Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 49.14B 7.38B 6.59B 6.09B 5.52B 10.32B 702B 10.52B 73.32B 29.01B 367B 27.69B 27.1B 1,162B | P/E 2026 * |
37.9x | P/E 2027 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise Value | 44.76B 6.72B 6B 5.55B 5.03B 9.4B 640B 9.59B 66.78B 26.42B 334B 25.22B 24.69B 1,059B | EV / Sales 2026 * |
5.55x | EV / Sales 2027 * | 4.6x |
| Free-Float |
62.13% | Yield 2026 * |
0.92% | Yield 2027 * | 1.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 1998-10-06 |
Rui Yang
CEO | Chief Executive Officer | 49 | 2022-01-18 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 2011-07-17 |
Hao Hong
CHM | Chairman | 70 | 1998-10-06 |
Ye Song
BRD | Director/Board Member | 65 | 2011-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 7.7B | ||
| +0.45% | +1.76% | +54.96% | +118.11% | 1,135B | ||
| +0.94% | +4.20% | +39.86% | +75.69% | 635B | ||
| +0.39% | +0.46% | +25.77% | +97.40% | 505B | ||
| +1.43% | +4.56% | +46.20% | +66.91% | 378B | ||
| -3.21% | -3.66% | +60.72% | +35.68% | 358B | ||
| -0.41% | +2.23% | +22.48% | +48.54% | 295B | ||
| +0.23% | +3.28% | +2.57% | +21.89% | 266B | ||
| +1.22% | +2.81% | +52.40% | +63.37% | 237B | ||
| +1.70% | +1.60% | +31.21% | +102.44% | 193B | ||
| Average | +0.52% | +1.60% | +37.35% | +70.00% | 444.85B | |
| Weighted average by Cap. | +0.42% | +1.63% | +41.40% | +81.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.06B 1.21B 1.08B 1B 906M 1.69B 115B 1.73B 12.03B 4.76B 60.22B 4.54B 4.45B 191B | 9.89B 1.48B 1.33B 1.23B 1.11B 2.08B 141B 2.12B 14.75B 5.84B 73.85B 5.57B 5.45B 234B |
| Net income | 1.33B 199M 178M 165M 149M 279M 18.97B 284M 1.98B 784M 9.92B 748M 732M 31.4B | 1.78B 267M 238M 220M 200M 373M 25.4B 381M 2.65B 1.05B 13.27B 1B 980M 42.03B |
| Net Debt | -4.38B -658M -588M -544M -492M -921M -62.65B -939M -6.54B -2.59B -32.74B -2.47B -2.42B -104B | -3.66B -550M -491M -454M -411M -769M -52.32B -784M -5.46B -2.16B -27.34B -2.06B -2.02B -86.58B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















